110 related articles for article (PubMed ID: 17669346)
1. [Preanalytical variations of proteic biomarkers].
Lambert D; Berrahmoune H; Herbeth B; Siest G; Visvikis-Siest S
Med Sci (Paris); 2007 Mar; 23 Spec No 1():9-12. PubMed ID: 17669346
[TBL] [Abstract][Full Text] [Related]
2. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples.
Rai AJ; Gelfand CA; Haywood BC; Warunek DJ; Yi J; Schuchard MD; Mehigh RJ; Cockrill SL; Scott GB; Tammen H; Schulz-Knappe P; Speicher DW; Vitzthum F; Haab BB; Siest G; Chan DW
Proteomics; 2005 Aug; 5(13):3262-77. PubMed ID: 16052621
[TBL] [Abstract][Full Text] [Related]
3. Influence of primary sample mixing on routine coagulation testing.
Lippi G; Salvagno GL; Montagnana M; Guidi GC
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):709-11. PubMed ID: 17890963
[No Abstract] [Full Text] [Related]
4. [Assessment of factors causing pre-analytic variabililty].
Minoia C
Ann Ist Super Sanita; 1995; 31(2):225-32. PubMed ID: 8561385
[TBL] [Abstract][Full Text] [Related]
5. Preanalytical biases in measurement of matrix metalloproteinases and their tissue inhibitors in peripheral blood.
Jung K
J Rheumatol; 2007 Apr; 34(4):890-2; author reply 892. PubMed ID: 17407248
[No Abstract] [Full Text] [Related]
6. Impact of blood collection devices on clinical chemistry assays.
Bowen RA; Hortin GL; Csako G; Otañez OH; Remaley AT
Clin Biochem; 2010 Jan; 43(1-2):4-25. PubMed ID: 19822139
[TBL] [Abstract][Full Text] [Related]
7. [Stakes of pre-analytical parameters in blood transcriptomic and proteomic analysis. Application to clinical research: the GOELAMS trial].
Pangault C; Arlotto M; Berger F; De Vos J; Béné MC; Fest T;
Med Sci (Paris); 2007 Mar; 23 Spec No 1():13-7. PubMed ID: 17669347
[TBL] [Abstract][Full Text] [Related]
8. Spiking of serum specimens with exogenous reporter peptides for mass spectrometry based protease profiling as diagnostic tool.
Findeisen P; Peccerella T; Post S; Wenz F; Neumaier M
Rapid Commun Mass Spectrom; 2008 Apr; 22(8):1223-9. PubMed ID: 18348224
[TBL] [Abstract][Full Text] [Related]
9. Specimen collection and handling.
Suryaatmadja M
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():158-65. PubMed ID: 10926276
[TBL] [Abstract][Full Text] [Related]
10. Morphological diagnosis of abetalipoproteinemia and the importance of a freshly prepared peripheral smear.
Anoop P; Parker-Williams J
Eur J Haematol; 2009 Dec; 83(6):606. PubMed ID: 19552676
[No Abstract] [Full Text] [Related]
11. The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF).
Rosenling T; Slim CL; Christin C; Coulier L; Shi S; Stoop MP; Bosman J; Suits F; Horvatovich PL; Stockhofe-Zurwieden N; Vreeken R; Hankemeier T; van Gool AJ; Luider TM; Bischoff R
J Proteome Res; 2009 Dec; 8(12):5511-22. PubMed ID: 19845411
[TBL] [Abstract][Full Text] [Related]
12. [Handling of biological material before trace element determination].
Caroli S; Coni E; Violante N; Petrucci F; Caimi S
Ann Ist Super Sanita; 1995; 31(2):219-24. PubMed ID: 8561384
[TBL] [Abstract][Full Text] [Related]
13. Progressive degradation of serum samples limits proteomic biomarker discovery.
Ahmad S; Sundaramoorthy E; Arora R; Sen S; Karthikeyan G; Sengupta S
Anal Biochem; 2009 Nov; 394(2):237-42. PubMed ID: 19632190
[TBL] [Abstract][Full Text] [Related]
14. Response to 'Multicenter evaluation of a bilayer polymer blood coagulation tube for coagulation testing: effect on routine hemostasis test results and on plasma levels of coagulation activation markers'.
Polack B
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):709. PubMed ID: 17890964
[No Abstract] [Full Text] [Related]
15. Banking of clinical samples for proteomic biomarker studies: a consideration of logistical issues with a focus on pre-analytical variation.
Jackson DH; Banks RE
Proteomics Clin Appl; 2010 Mar; 4(3):250-70. PubMed ID: 21137047
[TBL] [Abstract][Full Text] [Related]
16. [Towards a standardization of the tools for the studies of clinical proteomics].
Lucchi G; Hendra JB; Pecqueur D; Ducoroy P
Med Sci (Paris); 2007 Mar; 23 Spec No 1():19-22. PubMed ID: 17669348
[TBL] [Abstract][Full Text] [Related]
17. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display.
Tammen H; Schulte I; Hess R; Menzel C; Kellmann M; Mohring T; Schulz-Knappe P
Proteomics; 2005 Aug; 5(13):3414-22. PubMed ID: 16038021
[TBL] [Abstract][Full Text] [Related]
18. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
[TBL] [Abstract][Full Text] [Related]
19. Limited preanalytical requirements for insulin measurement.
Vogeser M; Parhofer KG
Clin Biochem; 2005 Jun; 38(6):572-5. PubMed ID: 15885238
[TBL] [Abstract][Full Text] [Related]
20. Stability of ribavirin concentrations depending on the type of blood collection tube and preanalytical conditions.
Marquet P; Sauvage FL; Loustaud-Ratti V; Babany G; Rousseau A; Lachâtre G
Ther Drug Monit; 2010 Apr; 32(2):237-41. PubMed ID: 20216114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
